FDA and DEA warned kubapharm.com it unlawfully sells high-abuse-risk stimulants, including Adderall, online without required registrations or prescriptions.
What happened
FDA reviewed the website and DEA reviewed its operations; no inspection is mentioned. The agencies found kubapharm.com offered amphetamine products such as "Buy Adderall Online Now" and advertised Schedule II controlled substances (drugs with high abuse potential) to U.S. consumers. DEA determined the site had no modified DEA registration (special registration for online sales of controlled substances), and FDA found the prescription drug offered without a prescription, making it misbranded (unlawfully labeled or sold under federal drug rules).
What FDA found
The website offered to distribute or dispense Schedule II stimulants, including amphetamine products, over the Internet without a modified DEA registration.
21 U.S.C. § 841(h)The website advertised controlled substances online and directed prospective buyers to Internet sellers that lacked valid modified DEA registration.
21 U.S.C. § 843(c)(2)(A)It offered Adderall, a prescription drug, for sale without requiring a prescription.
FD&C Act § 503(b)(1) [21 U.S.C. § 353(b)(1)]Offering the prescription drug without a prescription made the drug misbranded while held for sale.
FD&C Act § 301(k) [21 U.S.C. § 331(k)]The website caused misbranded drugs to be introduced into interstate commerce.
FD&C Act § 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA and DEA ask the company to take corrective action and notify both agencies in writing within 15 working days of receipt, with an explanation of each step and related documents; if it disagrees, it should send its reasoning and supporting information within that time.
Who should pay attention
- online pharmacies and websites selling prescription drugs
- telehealth and e-commerce platforms that connect buyers to controlled substances
- makers and distributors of Adderall and other Schedule II stimulants
This is a summary. Read the original letter on fda.gov.